Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04696471 · ClinicalTrials.gov registry record · NA

Effects of Theta Burst Stimulation on the Brain, Behavior, and Clinical Symptoms in Adults With Bipolar Disorder

A NA study, sponsored by Mary Phillips, MD MD (Cantab).

Completed
Registry status
NA
Development phase
146
Enrollment target

NCT04696471 is a NA study that has completed, run by Mary Phillips, MD MD (Cantab). The registered enrollment target is 146 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04696471, a NA study, has completed, sponsored by Mary Phillips, MD MD (Cantab).

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target

Study Summary

Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators aim to examine the immediate effect of transcranial brain stimulation (TBS) on brain activity and emotions in adults with and without BD as a first stage toward understanding the predisposing brain mechanisms of BD. The investigators hypothesize that TBS will reduce brain activity while playing a game with rewards in all adults, but the TBS will reduce brain activity more in the adults with BD compared to adults without BD. Furthermore, the investigators hypothesize that this reduced brain activity will be associated with reduced BD symptoms, such as negative emotions.

Interventions

  • DEVICE Continuous Theta Burst Stimulation (cTBS)
  • DEVICE Sham Continuous Theta Burst Stimulation (Sham cTBS)

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2021-04-06
Est. Completion 2025-10-24
Phase NA

Sponsor

Mary Phillips, MD MD (Cantab)

3 total trials

What the Registry Record Tells You About NCT04696471

The ClinicalTrials.gov registry entry for NCT04696471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mary Phillips, MD MD (Cantab), which has 3 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Continuous Theta Burst Stimulation (cTBS) is the first listed.

NCT04696471 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04696471 about?

NCT04696471 is a clinical study titled "Effects of Theta Burst Stimulation on the Brain, Behavior, and Clinical Symptoms in Adults With Bipolar Disorder". Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators aim to examine the immediate effect of transcranial brain stimulation (TBS) on brain activity and emotions in adults with and with...

What is the current status of trial NCT04696471?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2021-04-06. Estimated completion is 2025-10-24.

What interventions are being tested in trial NCT04696471?

The interventions under investigation include: Continuous Theta Burst Stimulation (cTBS) (DEVICE), Sham Continuous Theta Burst Stimulation (Sham cTBS) (DEVICE).

Who is sponsoring clinical trial NCT04696471?

This trial is sponsored by Mary Phillips, MD MD (Cantab), which has 3 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.